Edward G. D. Tuddenham

21.4k citations

251 papers · 13.5k indexed · 4 hit papers · h-index 61

Hematology top 0.02%
Molecular Biology top 2%
Genetics top 0.2%
Genetics top 0.5%
Pulmonary and Respiratory Medicine top 2%

Co-authors: Pier Mannuccio Mannucci John H. McVey Geoffrey Kemball‐Cook Richard M. Lawn Johannes Oldenburg Jane Gitschier D.N. Cooper Frances Rotblat
Topics: Hemophilia Treatment and Research (144 papers)Blood Coagulation and Thrombosis Mechanisms (115 papers)Platelet Disorders and Treatments (77 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: Nature New England Journal of Medicine The Lancet
Partner nations: United Kingdom United States Italy

In The Last Decade

Edward G. D. Tuddenham

246 papers receiving 12.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

2004 857 citations Edward G. D. Tuddenham et al. profile →
The Hemophilias — From Royal Genes to Gene Therapy

2001 774 citations Edward G. D. Tuddenham et al. profile →
Structure of human factor VIII

1984 717 citations Edward G. D. Tuddenham et al. profile →
Expression of active human factor VIII from recombinant DNA clones

1984 533 citations Edward G. D. Tuddenham et al. profile →

Peers

Countries citing papers authored by Edward G. D. Tuddenham

Since Specialization

Citations

This map shows the geographic impact of Edward G. D. Tuddenham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward G. D. Tuddenham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward G. D. Tuddenham more than expected).

Fields of papers citing papers by Edward G. D. Tuddenham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward G. D. Tuddenham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward G. D. Tuddenham. The network helps show where Edward G. D. Tuddenham may publish in the future.

Co-authorship network of co-authors of Edward G. D. Tuddenham

This figure shows the co-authorship network connecting the top 25 collaborators of Edward G. D. Tuddenham. A scholar is included among the top collaborators of Edward G. D. Tuddenham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward G. D. Tuddenham. Edward G. D. Tuddenham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibody 2025 ·Blood ·Vincent Muczynski,Olivier D. Christophe,(unknown),(unknown),Alain P. Guérin,Caterina Casari,Jenny McIntosh,(unknown),(unknown),Satyen H. Gohil,Peter J. Lenting,Edward G. D. Tuddenham,Amit Nathwani	0
2	The complex, confusing and poorly understood immune responses to AAV‐mediated gene transfer in haemophilia—Is more or less immunosuppression required? 2024 ·Journal of Viral Hepatitis ·Edward G. D. Tuddenham,Graham R. Foster	0
3	Mathematical models of coagulation—are we there yet? 2024 ·Journal of Thrombosis and Haemostasis ·(unknown),(unknown),Edward G. D. Tuddenham,John R. King,Alison H. Goodall,Joanne L. Dunster	3
4	Global coagulation assays in hemophilia A: A comparison to conventional assays 2019 ·Research and Practice in Thrombosis and Haemostasis ·(unknown),Anne Riddell,Christine A. Lee,Simon Brown,Edward G. D. Tuddenham,Pratima Chowdary	17
5	Adeno-Associated Mediated Gene Transfer for Hemophilia B:8 Year Follow up and Impact of Removing "Empty Viral Particles" on Safety and Efficacy of Gene Transfer 2018 ·Blood ·Amit C. Nathwani,Ulrike M. Reiss,Edward G. D. Tuddenham,Pratima Chowdary,Jenny McIntosh,Anne Riddell,(unknown),Johnny Mahlangu,Michael Recht,Yu‐Min Shen,Kathleen G. Halka,Michael M. Meagher,Arthur W. Nienhuis,Andrew M. Davidoff,Sarah Mangles,(unknown),Junfang Zhou,(unknown)	94
6	Advances in Gene Therapy for Haemophilia. 2017 ·Human Gene Therapy ·(unknown),(unknown),Edward G. D. Tuddenham	3
7	Advances in Gene Therapy for Hemophilia 2017 ·Human Gene Therapy ·Amit C. Nathwani,Andrew M. Davidoff,Edward G. D. Tuddenham	51
8	Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven^®] in elective orthopaedic surgery in haemophilic patients with inhibitors 2009 ·Haemophilia ·Paul Giangrande,J Wilde,(unknown),C A Ludlam,Edward G. D. Tuddenham,N J Goddard,G. Dolan,J. Ingerslev	55
9	The varieties of von Willebrand's disease 2008 ·Clinical & Laboratory Haematology ·Edward G. D. Tuddenham	0
10	Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow‐derived progenitor cells expressing membrane‐tethered anticoagulant fusion proteins 2006 ·Journal of Thrombosis and Haemostasis ·(unknown),Michele Weber,Paul G. Shiels,(unknown),Zoë Webster,John H. McVey,(unknown),Edward G. D. Tuddenham,Robert I. Lechler,Anthony Dorling	14
11	450 million years of hemostasis 2003 ·Journal of Thrombosis and Haemostasis ·C. Davidson,Edward G. D. Tuddenham,John H. McVey	113
12	Analysis of the consequences of premature termination codons within factor VIII coding sequences 2003 ·Journal of Thrombosis and Haemostasis ·D. David,(unknown),(unknown),Edward G. D. Tuddenham,John H. McVey	13
13	Use of a non‐depleting anti‐CD4 antibody to modulate the immune response to coagulation factors VIII and IX 2002 ·British Journal of Haematology ·Nina Salooja,Geoffrey Kemball‐Cook,Edward G. D. Tuddenham,Julian Dyson	13
14	Molecular Biological Aspects of Inhibitor Development 1999 ·Vox Sanguinis ·Edward G. D. Tuddenham	2
15	The genetic basis of inhibitor development in haemophilia A 1998 ·Haemophilia ·(unknown),Craig M. Kessler,D. Varon,U. Martinowitz,M. Heim,Edward G. D. Tuddenham,John H. McVey	35
16	Factor VIII gene analysis in Japanese CRM‐positive and CRM‐reduced haemophilia A patients by single‐strand conformation polymorphism 1997 ·British Journal of Haematology ·(unknown),Midori Shima,Seiki Kamisue,Ichiro Tanaka,(unknown),Hiroshi Suzuki,Hironobu Shibata,Susan Pemberton,Karen Gale,John H. McVey,Edward G. D. Tuddenham,Akira Yoshioka	7
17	EXPRESSION OF FACTOR-VII IN-VITRO AND IN-VIVO FOLLOWING DIRECT GENE-TRANSFER INTO MUSCLE - A MODEL FOR HEMOPHILIA 1995 ·UCL Discovery (University College London) ·Gaynor Miller,(unknown),(unknown),(unknown),Edward G. D. Tuddenham,(unknown),Geoffrey Goldspink,(unknown)	1
18	CRM⁺ haemophilia A due to a missense mutation (372→Cys) at the internal heavy chain thrombin cleavage site 1990 ·British Journal of Haematology ·J Pattinson,John H. McVey,M. E. Boon,(unknown),Edward G. D. Tuddenham	19
19	Desmopressin and bleeding time in patients with cirrhosis. 1985 ·BMJ ·A K Burroughs,(unknown),(unknown),Niclas Thomas,PB Kernoff,Edward G. D. Tuddenham,Neil McIntyre	68
20	The Physiology of Hemostasis 1984 ·Journal of the Royal Society of Medicine ·Edward G. D. Tuddenham	1

About Edward G. D. Tuddenham

Edward G. D. Tuddenham is a scholar working on Hematology, Genetics and Genetics, having authored 251 papers that have together received 13.5k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (144 papers), Blood Coagulation and Thrombosis Mechanisms (115 papers) and Platelet Disorders and Treatments (77 papers). The work is most often cited by research in Hematology (8.5k citations), Genetics (2.5k citations) and Internal Medicine (557 citations). Edward G. D. Tuddenham has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Pier Mannuccio Mannucci, John H. McVey, Geoffrey Kemball‐Cook, Richard M. Lawn, Johannes Oldenburg, Jane Gitschier, D.N. Cooper, Frances Rotblat, Donogh P. O'Brien and Amit C. Nathwani. Their work appears in journals such as Nature, New England Journal of Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact